Ocuphire Pharma, Inc.·4

Mar 25, 4:40 PM ET

Jhaveri Nirav S. 4

4 · Ocuphire Pharma, Inc. · Filed Mar 25, 2024

Insider Transaction Report

Form 4
Period: 2024-03-21
Jhaveri Nirav S.
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2024-03-21$2.10/sh+10,000$21,000150,000 total

Documents

1 file
  • 4
    form4.xmlPrimary